Showing 4021-4030 of 5646 results for "".
- Opthea Phase 2b Trial Results of OPT-302 in Combination with Lucentis for Wet AMD Meets Primary Endpointhttps://modernod.com/news/opthea-phase-2b-trial-results-of-opt-302-in-combination-with-lucentis-for-wet-amd-meets-primary-endpoint/2481405/Opthea announced that the phase 2b study results of OPT-302, the company’s anti-VEGF-C/-D “trap” agent administered in combination with Lucentis (ranibizumab) for the treatment of wet age-related macular degeneration (AMD), met the prespecified primary efficacy endpoint.
- Researchers Identify Potential Cause of Keratoconushttps://modernod.com/news/researchers-identify-potential-cause-of-keratoconus/2481402/Researchers at the University of North Texas Health Science Center are the first to characterize extracellular vesicles (EVs) in the tears of patients with keratoconus, according to an National Eye Institute news release. Dimitrios Karamichos, PhD, executive director of the North
- Eylea Approved as First Pharmacologic Treatment of Preterm Infants with ROPhttps://modernod.com/news/eylea-approved-as-first-pharmacologic-for-treatment-of-preterm-infants-with-rop/2481400/The FDA has approved Eylea (aflibercept) to treat preterm infants with retinopathy of prematurity (ROP). Following this first pediatric approval, Eylea is now indicated to treat five retinal conditions caused by ocular angiogenesis. “Retinopathy of prematurity is a leadi
- Study: Early Anti-VEGF Treatment of Diabetic Retinopathy Slows Progression but Yields No Benefit to Visual Acuityhttps://modernod.com/news/study-early-anti-vegf-treatment-of-diabetic-retinopathy-slows-progression-but-yields-no-benefit-to-visual-acuity/2481399/While early treatment of diabetes-related eye disease slowed progression to severe disease, it did not improve visual acuity compared with treating more severe disease once it developed, according to a clinical study from the DRCR Retina Network. The study was funded by the National Eye Institute
- IOT Introduces Neochromes Agile Dark Lenseshttps://modernod.com/news/iot-introduces-neochromes-agile-dark-lenses/2481397/Spain-based IOT has introduced Neochromes Agile Dark light activated lenses. Featuring exclusive dyes from IOT, the latest agile dark lenses are darker than the company's current Neochromes, yet are designed to fade back just as quickly, according to IOT. Th
- Omeros Receives $200 Million Milestone Payment from Raynerhttps://modernod.com/news/omeros-receives-200-million-milestone-payment-from-rayner/2481391/Omeros announced that Rayner has paid the $200 million milestone payment due to Omeros under the Asset Purchase Agreement, dated December 1, 2021, pursuant to which Omeros sold its ophthalmology product Omidria to Rayner in December of 2021. Omeros received
- Nidek Launches Cube Alpha Ophthalmic Surgical Systemhttps://modernod.com/news/nidek-launches-cube-a-ophthalmic-surgical-system/2481390/Nidek has announced the launch of the Cube α ophthalmic surgical system, which is designed to incorporate new ultrasound technology to deliver more powerful and effective phacoemulsification. According to Nidek, the Cube α incorporates Gyro torsional technolog
- Orbis Announces 3-Year Partnership with Hoya Vision Carehttps://modernod.com/news/orbis-announces-3-year-partnership-with-hoya-vision-care/2481389/Eye care nonprofit Orbis International announced a renewed partnership with Hoya, which will commit its support over the next 3 years with a focus on helping school children get access to eye care in low- to middle-income countries, and on training eye care professionals around the world thr
- Clearside Biomedical Announces Leadership Changeshttps://modernod.com/news/clearside-biomedical-announces-leadership-changes/2481386/Clearside Biomedical announced that its Chief Medical Officer and Chief Development Officer, Thomas A. Ciulla, MD, will transition to the role of Chief Medical Advisor-Retina for Clearside and step down from his full-time position, effective February 17, 2023. In his new advisory capacity, Dr. Ci
- Tracey Technologies Launches iTrace Prime Upgraded Software for iTrace Aberrometerhttps://modernod.com/news/tracey-technologies-launches-itrace-prime-upgraded-software-for-itrace-aberrometer/2481384/Tracey Technologies announced the release of iTrace Prime, an upgraded software for the iTrace Ray Tracing aberrometer and corneal topographer. This new software version (7.0) adds new features that improve the range of information able to be gathered from a single device, accordi